1. Cardiovascular and metabolic comorbidities as the factors for adverse events with ketamine;J Clinical Psychopharmacol,2023
2. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder;Cochrane Database Syst Rev,2021
3. A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders;Am J Psychiatry,2017
4. Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants;Adv Pharmacol,2020
5. Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2);J Clin Psychiatry,2020